BioSpace News Archive

INSYS Therapeutics Provides Update on NASDAQ Trading Hold

INSYS received a series of questions on Friday from NASDAQ.

October 31, 2017
·
2 min read
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients

Results of the economic analysis were presented as a late-breaking clinical trial at the 29th TCT.

October 31, 2017
·
5 min read
Pluristem Announces Pricing of Public Offering of Common Stock on the Tel Aviv Stock Exchange

The Company received overall orders for the purchase of approximately 13,500,000 shares at different prices for a total aggregate amount of approximately $21.8 million.

October 31, 2017
·
5 min read
Biotech Bay

Verseon to Present Preclinical Data on Novel Anticancer Candidates for Use against Multidrug Resistant Cancers

The results will be shown at the BIO-Europe conference held in Berlin from November 6–8, 2017.

October 31, 2017
·
1 min read
TCT 2017: BIOTRONIK Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in Clinical Practice

Data presented at the BIOTRONIK-sponsored symposium on the Orsiro1 drug-eluting stent (DES) demonstrate why Orsiro is gaining prominence in the crowded DES market.

October 31, 2017
·
3 min read
Policy

Tigenix Provides Regulatory Update on Cx601 EU Marketing Authorization Application Procedure - Oct. 31, 2017

An Oral Explanation is part of the MA Application procedure for many novel orphan drugs.

October 31, 2017
·
6 min read
Business

FibroGen to Report Third Quarter Financial Results on Wednesday, November 8, 2017

The company will host a conference call to discuss financial results and provide a business update at 5:00 p.m. ET (2:00 p.m. PT).

October 31, 2017
·
2 min read
Business

BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017

The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.

October 31, 2017
·
1 min read
Deals

Ablynx Closes on Underwriters’ Option to Purchase $30M of Additional Shares in the U.S. Initial Public Offering

The underwriters exercised their option to purchase additional ADSs, in full, on October 26, 2017.

October 31, 2017
·
6 min read
Business

OrthoPediatrics to Report Third Quarter 2017 Financial Results on November 8, 2017

OrthoPediatrics will host a conference call on Thursday, November 9, 2017 at 8:00 a.m. ET to discuss the results.

October 31, 2017
·
1 min read